iiCON consortium

The Infection Innovation Consortium (iiCON) is a global collaborative R&D program headquartered in Liverpool, UK, dedicated to accelerating the discovery and development of new products for infectious diseases. Led by the Liverpool School of Tropical Medicine, the consortium brings together industry, academia, and the NHS to streamline the journey from concept to clinical use. iiCON provides partners with access to world-leading R&D facilities, high-throughput screening, and clinical trial capabilities. Its primary focus areas include antimicrobial resistance, emerging viral threats, and neglected tropical diseases. By fostering innovation in therapeutics, diagnostics, and preventative measures, iiCON aims to strengthen the global response to infectious disease challenges.